M. Center, A. Jemmal, J. Lortet-tieulent, E. Ward, J. Ferlay et al., International Variation in Prostate Cancer Incidence and Mortality Rates, European Urology, vol.61, issue.6, p.22424666, 2012.
DOI : 10.1016/j.eururo.2012.02.054

A. Hsing and A. Chokkalingam, Prostate cancer epidemiology, Frontiers in Bioscience, vol.11, issue.1, pp.1388-1413, 2006.
DOI : 10.2741/1891

J. Damber and G. Aus, Prostate cancer, The Lancet, vol.371, issue.9625, pp.1710-1721, 2008.
DOI : 10.1016/S0140-6736(08)60729-1

M. Bosland, The role of steroid hormones in prostate carcinogenesis, J Natl Cancer Inst Monogr, vol.27, pp.39-66, 2000.

G. Carruba, Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario, Journal of Cellular Biochemistry, vol.354, issue.255, pp.899-911, 2007.
DOI : 10.1042/bse0400011

E. Rogan and E. Cavalieri, Estrogen Metabolites, Conjugates, and DNA Adducts: Possible Biomarkers for Risk of Breast, Prostate, and Other Human Cancers, Adv Clin Chem, vol.38, pp.135-149, 2004.
DOI : 10.1016/S0065-2423(04)38005-4

M. Yuen, L. Leung, J. Wang, Y. Wong, and F. Chan, Enhanced induction of prostatic dysplasia and carcinoma in Noble rat model by combination of neonatal estrogen exposure and hormonal treatments at adulthood, Int J Oncol, vol.27, pp.1685-1695, 2005.

O. Cussenot, A. Azzouzi, N. Nicolaiew, G. Fromont, P. Mangin et al., Combination of Polymorphisms From Genes Related to Estrogen Metabolism and Risk of Prostate Cancers: The Hidden Face of Estrogens, Journal of Clinical Oncology, vol.25, issue.24, pp.3596-3602, 2007.
DOI : 10.1200/JCO.2007.11.0908

G. Cancel-tassin and O. Cussenot, Genetic susceptibility to prostate cancer, BJU International, vol.12, issue.9, pp.1380-1385, 2005.
DOI : 10.1007/s004390051102

L. Sharp, A. Cardy, S. Cotton, and J. Little, CYP17 Gene Polymorphisms: Prevalence and Associations with Hormone Levels and Related Factors. A HuGE Review, American Journal of Epidemiology, vol.160, issue.8, pp.729-740, 2004.
DOI : 10.1093/aje/kwh287

URL : https://academic.oup.com/aje/article-pdf/160/8/729/370883/kwh287.pdf

S. Olson, E. Bandera, and I. Orlow, Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE Review, American Journal of Epidemiology, vol.38, issue.3, pp.235-245, 2007.
DOI : 10.1021/bi9821059

URL : https://academic.oup.com/aje/article-pdf/165/3/235/17337337/kwk015.pdf

I. Hanna, S. Dawling, N. Roodi, F. Guengerich, and F. Parl, Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity, Cancer Res, vol.60, pp.3440-3444, 2000.

T. Lotta, J. Vidgren, C. Tilgmann, I. Ulmanen, K. Melén et al., Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme, Biochemistry, vol.34, issue.13, pp.4202-4210, 1995.
DOI : 10.1021/bi00013a008

G. Zhu, R. Lipsky, K. Xu, S. Ali, T. Hyde et al., Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5? nuclease assay, Psychopharmacology, vol.299, issue.1-2, pp.178-184, 2004.
DOI : 10.1126/science.1078546

Z. Cheng, G. Rios, C. King, B. Coffman, M. Green et al., Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7, Toxicol Sci, vol.45, pp.52-57, 1998.
DOI : 10.1093/toxsci/45.1.52

URL : https://academic.oup.com/toxsci/article-pdf/45/1/52/4826038/45-1-52.pdf

P. Bosma, J. Chowdhury, C. Bakker, S. Gantla, A. De-boer et al., The Genetic Basis of the Reduced Expression of Bilirubin UDP-Glucuronosyltransferase 1 in Gilbert's Syndrome, New England Journal of Medicine, vol.333, issue.18, pp.1171-1175, 1995.
DOI : 10.1056/NEJM199511023331802

, Available: http://www.insee.fr/ [accessed 29, INSEE. Institut National de la Statistique et des Etudes Economiques, 2016.

, Bulletin de Veille Sanitaire Antilles- Guyane n°8, La surveillance des cancers dans les Antilles et en Guyane, 2011.

Y. Ben-shlomo, S. Evans, F. Ibrahim, B. Patel, K. Anson et al., The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort Study, European Urology, vol.53, issue.1, pp.99-105, 2008.
DOI : 10.1016/j.eururo.2007.02.047

, Cancer Facts & Figures for African Americans, 2007.

. Globocan, http://globocan.iarc.fr/ [accessed 28, 2012.

L. Multigner, J. Ndong, A. Giusti, M. Romana, H. Delacroix-maillard et al., Chlordecone Exposure and Risk of Prostate Cancer, Journal of Clinical Oncology, vol.28, issue.21, pp.3457-3462, 2010.
DOI : 10.1200/JCO.2009.27.2153

URL : https://hal.archives-ouvertes.fr/inserm-00518099

T. Morgan, S. Jacobsen, W. Mccarthy, D. Jacobson, D. Mcleod et al., Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men, New England Journal of Medicine, vol.335, issue.5, pp.304-310, 1996.
DOI : 10.1056/NEJM199608013350502

K. Rothman and S. Greenland, Introduction to stratified analysis, Modern Epidemiology. Lippincott-Raven, pp.253-279, 1998.

N. Tsuchiya, L. Wang, H. Suzuki, T. Segawa, H. Fukuda et al., Gene Polymorphisms on the Survival of Patients With Metastatic Prostate Cancer, Journal of Clinical Oncology, vol.24, issue.13, pp.1982-1989, 2006.
DOI : 10.1200/JCO.2005.02.9439

S. Sherry, M. Ward, M. Kholodov, J. Baker, L. Phan et al., dbSNP: the NCBI database of genetic variation, Nucleic Acids Research, vol.29, issue.1, pp.308-311, 2001.
DOI : 10.1093/nar/29.1.308

URL : https://academic.oup.com/nar/article-pdf/29/1/308/9905801/290308.pdf

R. Lunn, D. Bell, J. Mohler, and J. Taylor, Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2), Carcinogenesis, vol.20, issue.9, pp.1727-1731, 1999.
DOI : 10.1093/carcin/20.9.1727

R. Kittles, R. Panguluri, W. Chen, A. Massac, C. Ahaghotu et al., Cyp17 promoter variant associated with prostate canceraggressiveness in African Americans, Cancer Epidemiol. Biomarkers Prev, vol.10, pp.943-947, 2001.

J. Stanford, E. Noonan, L. Iwasaki, S. Kolb, R. Chadwick et al., A polymorphism in the CYP17 gene and risk of prostate cancer, Cancer Epidemiol. Biomarkers Prev, vol.11, pp.243-247, 2002.

M. Cicek, D. Conti, A. Curran, P. Neville, P. Paris et al., Association of prostate cancer risk and aggressiveness to androgen pathway genes:SRD5A2,CYP17, and theAR, The Prostate, vol.1, issue.1, pp.69-76, 2004.
DOI : 10.1038/nm0295-99

A. Sarma, R. Dunn, L. Lange, A. Ray, Y. Wang et al., Genetic polymorphisms inCYP17,CYP3A4,CYP19A1,SRD5A2,IGF-1, andIGFBP-3 and prostate cancer risk in African-American men: The Flint Men's Health Study, The Prostate, vol.8, issue.3, pp.296-305, 2008.
DOI : 10.1038/ncpuro0091

URL : http://europepmc.org/articles/pmc2712831?pdf=render

J. Beuten, J. Gelfond, J. Franke, K. Weldon, A. Crandall et al., Single and Multigenic Analysis of the Association between Variants in 12 Steroid Hormone Metabolism Genes and Risk of Prostate Cancer, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.6, pp.1869-1880, 2009.
DOI : 10.1158/1055-9965.EPI-09-0076

D. Santos, A. Ribeiro, M. Mesquita, J. Carvalho-salles, A. Hackel et al., No association of the 5??? promoter region polymorphism of CYP17 gene with prostate cancer risk, Prostate Cancer and Prostatic Diseases, vol.91, issue.Suppl 1, pp.28-31, 2002.
DOI : 10.1111/j.1349-7006.2000.tb01029.x

F. Wang, Y. Zou, X. Feng, H. Su, and F. Huang, CYP17 gene polymorphisms and prostate cancer risk: A meta-analysis based on 38 independent studies, The Prostate, vol.123, issue.114, pp.1167-1177, 2011.
DOI : 10.1007/s00439-007-0454-8

C. Ragin, S. Langevin, S. Rubin, and E. Taioli, Review of studies on metabolic genes and cancer in populations of African descent, Genetics in Medicine, vol.160, issue.1, 2010.
DOI : 10.1093/aje/kwh294

E. Taioli, V. Sears, A. Watson, R. Flores-obando, M. Jackson et al., and prostate cancer in men of African descent, The Prostate, vol.160, issue.4, pp.668-676, 2013.
DOI : 10.1093/aje/kwh294

L. Li, M. Cicek, G. Casey, and J. Witte, No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancer, Cancer Epidemiol Biomarkers Prev, vol.13, pp.2280-2281, 2004.

K. Suzuki, H. Nakazato, H. Matsui, H. Koike, H. Okugi et al., Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population, Anticancer Res, vol.23, pp.4941-4946, 2003.

L. Cui, K. Dillehay, W. Chen, D. Shen, Z. Dong et al., Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis, Molecular Biology Reports, vol.14, issue.1, pp.7465-7471, 2012.
DOI : 10.1158/1078-0432.CCR-04-2545

L. Zou, X. Xu, T. Liu, H. Wang, W. Fan et al., Val158Met Polymorphism and Prostate Cancer Risk: A Meta-Analysis, Genetic Testing and Molecular Biomarkers, vol.17, issue.1, pp.78-84, 2013.
DOI : 10.1089/gtmb.2012.0216

H. Zhang, Z. Zhang, J. Wu, Y. Xu, R. Cheng et al., Lack of Association between COMT Val158Met Polymorphism and Prostate Cancer Susceptibility, Urologia Internationalis, vol.91, issue.2, pp.213-219, 2013.
DOI : 10.1159/000345633

L. Xiao, M. Tong, J. Y. Huang, W. Li, and Z. , The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis, Molecular Biology Reports, vol.14, issue.2, pp.1835-1841, 2013.
DOI : 10.1158/1055-9965.EPI-04-0479

A. Wu, C. Tseng, . Van-den, D. Berg, and M. Yu, Tea intake, COMT genotype, and breast cancer in Asian-American women, Cancer Res, vol.63, pp.7526-7529, 2003.
DOI : 10.1002/ijc.22387

URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.22387/pdf

B. Zhu, U. Patel, M. Cai, and A. Conney, O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase, Drug Metab Dispos, vol.28, pp.1024-1030, 2000.

M. Inoue-choi, J. Yuan, C. Yang, . Van-den, D. Berg et al., Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers, Int J Mol Epidemiol Genet, vol.1, pp.114-123, 2010.

A. Karatzas, E. Giannatou, V. Tzortzis, S. Gravas, E. Aravantinos et al., Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men, Cancer Epidemiology, vol.34, issue.3, pp.345-349, 2010.
DOI : 10.1016/j.canep.2010.02.009

L. Tang, S. Yao, C. Till, P. Goodman, C. Tangen et al., Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial, Carcinogenesis, vol.45, issue.10, pp.1500-1506, 2011.
DOI : 10.1016/j.canep.2010.02.009

K. Rothman, No Adjustments Are Needed for Multiple Comparisons, Epidemiology, vol.1, issue.1, pp.43-46, 1990.
DOI : 10.1097/00001648-199001000-00010